Professor of Psychiatry and Human Behavior, Professor of Obstetrics and Gynecology, Professor of Behavioral and Social Sciences


Dr. Stroud serves as Director and Senior Research Scientist at the Center for Behavioral and Preventive Medicine at The Miriam Hospital. She serves as Director and Principal Investigator of the COBRE Center for Stress, Trauma, and Resilience (STAR) and Founding Director of the Maternal-Infant Studies Laboratory and the Child and Adolescent Stress Laboratory at The Miriam Hospital. Dr. Stroud is a dedicated mentor and co-directs the STAR T32, a postdoctoral fellowship program focused on the impact of childhood stress, trauma, and resilience across the lifespan, and received the 2023 Faculty Mentoring Award from the Department of Psychiatry and Human Behavior.

Dr. Stroud’s research focuses on biobehavioral mechanisms of mood and addictive disorders. Her work involves a transdisciplinary, developmental framework incorporating both neurobiological and behavioral markers of risk and a focus on novel neurobehavioral and stress response paradigms. Her work focuses on two sensitive periods of development: fetal-infant transition and the adolescent/pubertal transition. Within the fetal-infant period, Dr. Stroud's work has focused on novel ultrasound measures of fetal development and biological  pathways through which effects of maternal stress, substance use, and depression are transmitted to the fetus and infant. She has also developed a new line of research focused on the impact of marijuana use and novel tobacco products (hookah, electronic cigarettes) on pregnant mothers and infants. Within the adolescent period, Dr. Stroud’s work has focused on novel neural and neuroendocrine biomarkers of risk for adolescent depression.

Dr. Stroud has been continuously funded by the National Institutes of Health since 2001. She has also been the recipient of three NARSAD awards from the Brain and Behavior Research Foundation, and funding from the National Science Foundation, the US Food and Drug Administration (FDA), and the Robert Wood Johnson foundation. Dr. Stroud served as a Contributing Author on the 2016 Surgeon General Report, E-Cigarette Use in Youth and Young Adults and as the 2022 Stephen E. Straus Distinguished Lecturer at the National Center for Complementary and Integrative Health (NCCIH). Dr. Stroud currently serves on the editorial board for Neurotoxicology and Teratology, and also served as Associate Editor for Nicotine and Tobacco Research. She was the recipient of the Bruce Selya Research Excellence Award from Lifespan Hospitals and the Outstanding Early Career Investigator Award from the National Institute on Drug Abuse. 

Dr. Laura Stroud has an AB in Human Biology from Stanford University, and received a PhD in Psychology from Yale University in 1999. She completed her postdoctoral fellowship at Brown in 2001, then joined the faculty in the Department of Psychiatry and Human Behavior at Brown. Dr. Stroud also holds secondary appointments in the Department of Obstetrics and Gynecology, and in Behavioral and Social Sciences in the School of Public Health at Brown. 

Brown Affiliations

Research Areas

On the Web